Carregant...
Construction of an immune-related signature with prognostic value for colon cancer
BACKGROUND: Colon cancer is the third most common malignant tumor in the world. Although immunotherapy has been used in cancer treatment, there is still no first-line immunotherapy method for colon cancer. Therefore, it is essential to search for potential immunotherapy targets and molecular biomark...
Guardat en:
| Publicat a: | PeerJ |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PeerJ Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106397/ https://ncbi.nlm.nih.gov/pubmed/33996273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10812 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|